Luteolin Alleviates Oxidative Stress in Chronic Obstructive Pulmonary Disease Induced by Cigarette Smoke via Modulation of the TRPV1 and CYP2A13/NRF2 Signaling Pathways
Open Access
- 27 December 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (1) , 369
Abstract
The current study aims to investigate the therapeutic potential of luteolin (Lut), a naturally occurring flavonoid found in various medicinal plants, for treating chronic obstructive pulmonary disease (COPD) through both in vitro and in vivo studies. The results demonstrated that Lut increased body weight, reduced lung tissue swelling and lung damage indices, mitigated systemic oxidative stress levels, and decreased alveolar fusion in cigarette smoke (CS)- and lipopolysaccharide (LPS)-induced COPD mice. Additionally, Lut was observed to downregulate the expression of the TRPV1 and CYP2A13 proteins while upregulating SIRT6 and NRF2 protein expression in CS + LPS-induced COPD mice and cigarette smoke extract (CSE)-treated A549 cells. The concentrations of total reactive oxygen species (ROS) and mitochondrial ROS in A549 cells induced by CSE significantly increased. Moreover, CSE caused a notable elevation of intracellular Ca2+ levels in A549 cells. Importantly, Lut exhibited inhibitory effects on the inward flow of Ca2+ and attenuated the overproduction of mitochondrial and intracellular ROS in A549 cells treated with CSE. In conclusion, Lut demonstrated a protective role in alleviating oxidative stress and inflammation in CS + LPS-induced COPD mice and CSE-treated A549 cells by regulating TRPV1/SIRT6 and CYP2A13/NRF2 signaling pathways.Keywords
Funding Information
- National Natural Science Foundation of China (32000262, BM2018021-4)
- Provincial Public Welfare Research Institutes Independent Research Projects (32000262, BM2018021-4)
- Jiangsu Scientific and Technological Innovations Platform named Jiangsu Provincial Service Center for Antidiabetic Drug Screening (32000262, BM2018021-4)
This publication has 78 references indexed in Scilit:
- Lung inflammation in COPD: why does it matter?F1000 Medicine Reports, 2012
- Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging diseaseInternational Journal of Chronic Obstructive Pulmonary Disease, 2012
- Consequences of Hyperoxia and the Toxicity of Oxygen in the LungNursing Research and Practice, 2011
- Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Epigenetic Effects and Molecular Mechanisms of Tumorigenesis Induced by Cigarette Smoke: An OverviewJournal of Oncology, 2011
- Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPDJournal of Inflammation, 2010
- The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative StressJournal of Biological Chemistry, 2009
- Relative contributions of TRPA1 and TRPV1 channels in the activation of vagal bronchopulmonary C‐fibres by the endogenous autacoid 4‐oxononenalThe Journal of Physiology, 2008
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- CYP2A13 in Human Respiratory Tissues and Lung Cancers: An Immunohistochemical Study with A New Peptide-Specific AntibodyDrug Metabolism and Disposition, 2006